GlassScriptPhysician profile
Bindubal K Balan
NPI 1093890287
$1,317.63
in general payments reported to CMS, 2019-2025
18 companies · $381 in 2025
The $381 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2020: $122 · 2021: $98.55 · 2022: $127 · 2023: $194 · 2024: $271 · 2025: $381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $823 · Education: $24.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $822.79 |
| Education | $24.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $453.91 | 2019-2025 | |
| Abbvie INC. | $276.60 | 2019-2025 | Ubrelvy, Skyrizi, Synthroid |
| Glaxosmithkline, LLC. | $104.15 | 2019-2025 | Shingrix |
| Astellas Pharma US INC | $92.13 | 2019-2024 | Veozah |
| Janssen Biotech, INC. | $85.24 | 2020-2022 | |
| Dexcom, INC. | $81.46 | 2022-2025 | Dexcom G6 Transmitter |
| Medtronic, INC. | $44.07 | 2022 | |
| Neurocrine Biosciences, INC. | $24.04 | 2025 | |
| Acella Pharmaceuticals, LLC | $20.80 | 2019 | |
| Boston Scientific Corporation | $20.72 | 2019 | |
| Sandoz INC. | $16.82 | 2025 | Jubbonti |
| Irhythm Technologies, INC. | $15.47 | 2024 | Zio Monitor, Zio Xt Patch |
| E.R. Squibb & Sons, L.L.C. | $15.26 | 2021 | |
| Abbott Laboratories | $14.81 | 2023 | Proclaim |
| Inspire Medical Systems, INC. | $14.45 | 2025 | Inspire |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $13.38 | 2019 | |
| Eisai INC. | $13.25 | 2021 | |
| Medtronic Minimed, INC. | $11.07 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bindubal Balan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.